Separate terms with OR to return results that match either term.
 
Clear All

10,000 Matching ResultsExport these results
Click column titles once to sort ascending, and twice to sort descending.
Show Entries
NDC-11 (Package) NDC-9 (Product) Generic Name Brand Name Strength SEER*Rx Category Major Class Minor Class Administration Route (Descending) Package Effective Date Package Discontinuation Date Status
62175-0243-19 62175-0243 Temozolomide Temozolomide 140.0 mg/1 Chemotherapy Alkylating Agent Tetrazine Oral Feb. 10, 2016 In Use
62175-0243-24 62175-0243 Temozolomide Temozolomide 140.0 mg/1 Chemotherapy Alkylating Agent Tetrazine Oral Feb. 10, 2016 In Use
62175-0244-19 62175-0244 Temozolomide Temozolomide 180.0 mg/1 Chemotherapy Alkylating Agent Tetrazine Oral Feb. 10, 2016 In Use
62175-0244-24 62175-0244 Temozolomide Temozolomide 180.0 mg/1 Chemotherapy Alkylating Agent Tetrazine Oral Feb. 10, 2016 In Use
62175-0245-19 62175-0245 Temozolomide Temozolomide 250.0 mg/1 Chemotherapy Alkylating Agent Tetrazine Oral Feb. 10, 2016 In Use
62175-0245-24 62175-0245 Temozolomide Temozolomide 250.0 mg/1 Chemotherapy Alkylating Agent Tetrazine Oral Feb. 10, 2016 In Use
68788-7892-01 68788-7892 Estradiol Estradiol 0.5 mg/1 Hormonal Therapy Estrogen Oral April 23, 2021 May 30, 2023 No Longer Used
68788-7892-03 68788-7892 Estradiol Estradiol 0.5 mg/1 Hormonal Therapy Estrogen Oral April 23, 2021 May 30, 2023 No Longer Used
68788-7892-06 68788-7892 Estradiol Estradiol 0.5 mg/1 Hormonal Therapy Estrogen Oral April 23, 2021 May 30, 2023 No Longer Used
68788-7892-09 68788-7892 Estradiol Estradiol 0.5 mg/1 Hormonal Therapy Estrogen Oral April 23, 2021 May 30, 2023 No Longer Used
70934-0927-30 70934-0927 Estradiol Estradiol 1.0 mg/1 Hormonal Therapy Estrogen Oral Nov. 24, 2021 In Use
70934-0927-90 70934-0927 Estradiol Estradiol 1.0 mg/1 Hormonal Therapy Estrogen Oral Nov. 24, 2021 In Use
76388-0713-25 76388-0713 Busulfan Myleran 2.0 mg/1 Chemotherapy Alkylating Agent Alkylsulfonate Oral March 21, 1985 June 30, 2023 No Longer Used
63629-2068-01 63629-2068 IMATINIB MESYLATE IMATINIB MESYLATE 400.0 mg/1 Chemotherapy Tyrosine Kinase Inhibitor BCR-ABL Oral Feb. 8, 2019 June 30, 2023 No Longer Used
68071-3268-01 68071-3268 Ondansetron Ondansetron 4.0 mg/1 Ancillary Therapy Antiemetic 5HT3 Receptor Antagonist Oral May 23, 2017 In Use
68071-3268-02 68071-3268 Ondansetron Ondansetron 4.0 mg/1 Ancillary Therapy Antiemetic 5HT3 Receptor Antagonist Oral May 23, 2017 In Use
68071-3268-07 68071-3268 Ondansetron Ondansetron 4.0 mg/1 Ancillary Therapy Antiemetic 5HT3 Receptor Antagonist Oral May 23, 2017 In Use
68071-3268-03 68071-3268 Ondansetron Ondansetron 4.0 mg/1 Ancillary Therapy Antiemetic 5HT3 Receptor Antagonist Oral May 23, 2017 In Use
68071-3268-04 68071-3268 Ondansetron Ondansetron 4.0 mg/1 Ancillary Therapy Antiemetic 5HT3 Receptor Antagonist Oral May 23, 2017 In Use
68071-3268-06 68071-3268 Ondansetron Ondansetron 4.0 mg/1 Ancillary Therapy Antiemetic 5HT3 Receptor Antagonist Oral May 23, 2017 In Use
68071-3268-05 68071-3268 Ondansetron Ondansetron 4.0 mg/1 Ancillary Therapy Antiemetic 5HT3 Receptor Antagonist Oral May 23, 2017 In Use
67296-2081-01 67296-2081 Prednisone Prednisone 20.0 mg/1 Hormonal Therapy Adrenal Glucocorticoid Corticosteroid Oral June 24, 2020 In Use
67296-2081-02 67296-2081 Prednisone Prednisone 20.0 mg/1 Hormonal Therapy Adrenal Glucocorticoid Corticosteroid Oral June 24, 2020 In Use
67296-2081-05 67296-2081 Prednisone Prednisone 20.0 mg/1 Hormonal Therapy Adrenal Glucocorticoid Corticosteroid Oral June 24, 2020 In Use
70518-1551-00 70518-1551 Ondansetron Ondansetron 8.0 mg/1 Ancillary Therapy Antiemetic 5HT3 Receptor Antagonist Oral Oct. 23, 2018 In Use

Found 10,000 results in 8 millisecondsExport these results